Serum Institute sought Emergency Use Authorisation of Oxford Vaccine in India
Serum Institute became the first Indian firm to apply to DCGI on the same
U.S firm Pfizer was the first-ever company to seek approval in India
Serum Institute is currently doing phase III trials of Oxford’s Covishield vaccine
Based on results, the Serum Institute will try for early availability of vaccine in India
